vs
LIQUIDITY SERVICES INC（LQDT）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Ultragenyx Pharmaceutical Inc.的季度营收约是LIQUIDITY SERVICES INC的1.7倍（$207.3M vs $121.2M），LIQUIDITY SERVICES INC净利率更高（6.2% vs -62.0%，领先68.2%），Ultragenyx Pharmaceutical Inc.同比增速更快（25.9% vs -0.9%），LIQUIDITY SERVICES INC自由现金流更多（$-2.8M vs $-100.8M），过去两年Ultragenyx Pharmaceutical Inc.的营收复合增速更高（38.0% vs 15.1%）
利魁迪提服务公司是一家美国电子商务企业，依托线上交易平台网络为客户提供过剩资产管理服务，助力各类企业及政府机构转售过剩库存、退回商品及报废货品。公司成立于1999年，总部设在美国马里兰州贝塞斯达。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
LQDT vs RARE — 直观对比
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $121.2M | $207.3M |
| 净利润 | $7.5M | $-128.6M |
| 毛利率 | 47.0% | — |
| 营业利润率 | 7.7% | -54.7% |
| 净利率 | 6.2% | -62.0% |
| 营收同比 | -0.9% | 25.9% |
| 净利润同比 | 28.9% | 3.5% |
| 每股收益（稀释后） | $0.23 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $121.2M | $207.3M | ||
| Q3 25 | $118.1M | $159.9M | ||
| Q2 25 | $119.9M | $166.5M | ||
| Q1 25 | $116.4M | $139.3M | ||
| Q4 24 | $122.3M | $164.6M | ||
| Q3 24 | $106.9M | $139.5M | ||
| Q2 24 | $93.6M | $147.0M | ||
| Q1 24 | $91.5M | $108.8M |
| Q4 25 | $7.5M | $-128.6M | ||
| Q3 25 | $7.8M | $-180.4M | ||
| Q2 25 | $7.4M | $-115.0M | ||
| Q1 25 | $7.1M | $-151.1M | ||
| Q4 24 | $5.8M | $-133.2M | ||
| Q3 24 | $6.4M | $-133.5M | ||
| Q2 24 | $6.0M | $-131.6M | ||
| Q1 24 | $5.7M | $-170.7M |
| Q4 25 | 47.0% | — | ||
| Q3 25 | 47.8% | — | ||
| Q2 25 | 45.7% | — | ||
| Q1 25 | 40.8% | — | ||
| Q4 24 | 41.0% | — | ||
| Q3 24 | 45.6% | — | ||
| Q2 24 | 52.8% | — | ||
| Q1 24 | 51.6% | — |
| Q4 25 | 7.7% | -54.7% | ||
| Q3 25 | 9.3% | -106.9% | ||
| Q2 25 | 8.5% | -64.8% | ||
| Q1 25 | 5.8% | -102.6% | ||
| Q4 24 | 5.8% | -74.3% | ||
| Q3 24 | 6.8% | -94.6% | ||
| Q2 24 | 8.4% | -79.1% | ||
| Q1 24 | 7.2% | -151.9% |
| Q4 25 | 6.2% | -62.0% | ||
| Q3 25 | 6.6% | -112.8% | ||
| Q2 25 | 6.2% | -69.0% | ||
| Q1 25 | 6.1% | -108.5% | ||
| Q4 24 | 4.7% | -80.9% | ||
| Q3 24 | 6.0% | -95.7% | ||
| Q2 24 | 6.4% | -89.5% | ||
| Q1 24 | 6.2% | -156.8% |
| Q4 25 | $0.23 | $-1.28 | ||
| Q3 25 | $0.24 | $-1.81 | ||
| Q2 25 | $0.23 | $-1.17 | ||
| Q1 25 | $0.22 | $-1.57 | ||
| Q4 24 | $0.18 | $-1.34 | ||
| Q3 24 | $0.20 | $-1.40 | ||
| Q2 24 | $0.19 | $-1.52 | ||
| Q1 24 | $0.18 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $11.6M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $215.3M | $-80.0M |
| 总资产 | $369.1M | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $11.6M | $421.0M | ||
| Q3 25 | $11.2M | $202.5M | ||
| Q2 25 | $11.4M | $176.3M | ||
| Q1 25 | $10.5M | $127.1M | ||
| Q4 24 | $10.4M | $174.0M | ||
| Q3 24 | $2.3M | $150.6M | ||
| Q2 24 | $6.5M | $480.7M | ||
| Q1 24 | $8.4M | $112.3M |
| Q4 25 | $215.3M | $-80.0M | ||
| Q3 25 | $203.2M | $9.2M | ||
| Q2 25 | $208.7M | $151.3M | ||
| Q1 25 | $196.3M | $144.2M | ||
| Q4 24 | $189.2M | $255.0M | ||
| Q3 24 | $182.6M | $346.8M | ||
| Q2 24 | $172.0M | $432.4M | ||
| Q1 24 | $163.9M | $140.3M |
| Q4 25 | $369.1M | $1.5B | ||
| Q3 25 | $375.1M | $1.2B | ||
| Q2 25 | $372.4M | $1.3B | ||
| Q1 25 | $358.8M | $1.3B | ||
| Q4 24 | $333.2M | $1.5B | ||
| Q3 24 | $346.9M | $1.5B | ||
| Q2 24 | $325.5M | $1.6B | ||
| Q1 24 | $303.7M | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-526.0K | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-2.8M | $-100.8M |
| 自由现金流率自由现金流/营收 | -2.3% | -48.6% |
| 资本支出强度资本支出/营收 | 1.9% | 0.5% |
| 现金转化率经营现金流/净利润 | -0.07× | — |
| 过去12个月自由现金流最近4个季度 | $70.1M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-526.0K | $-99.8M | ||
| Q3 25 | $38.0M | $-91.4M | ||
| Q2 25 | $19.3M | $-108.3M | ||
| Q1 25 | $21.6M | $-166.5M | ||
| Q4 24 | $-12.1M | $-79.3M | ||
| Q3 24 | $22.0M | $-67.0M | ||
| Q2 24 | $22.2M | $-77.0M | ||
| Q1 24 | $34.8M | $-190.7M |
| Q4 25 | $-2.8M | $-100.8M | ||
| Q3 25 | $36.0M | $-92.7M | ||
| Q2 25 | $17.2M | $-110.7M | ||
| Q1 25 | $19.8M | $-167.8M | ||
| Q4 24 | $-14.0M | $-79.5M | ||
| Q3 24 | $19.2M | $-68.6M | ||
| Q2 24 | $20.3M | $-79.0M | ||
| Q1 24 | $32.5M | $-193.9M |
| Q4 25 | -2.3% | -48.6% | ||
| Q3 25 | 30.5% | -58.0% | ||
| Q2 25 | 14.3% | -66.5% | ||
| Q1 25 | 17.0% | -120.5% | ||
| Q4 24 | -11.4% | -48.3% | ||
| Q3 24 | 17.9% | -49.2% | ||
| Q2 24 | 21.7% | -53.7% | ||
| Q1 24 | 35.5% | -178.2% |
| Q4 25 | 1.9% | 0.5% | ||
| Q3 25 | 1.7% | 0.8% | ||
| Q2 25 | 1.8% | 1.5% | ||
| Q1 25 | 1.6% | 1.0% | ||
| Q4 24 | 1.5% | 0.1% | ||
| Q3 24 | 2.7% | 1.2% | ||
| Q2 24 | 2.1% | 1.4% | ||
| Q1 24 | 2.6% | 3.0% |
| Q4 25 | -0.07× | — | ||
| Q3 25 | 4.86× | — | ||
| Q2 25 | 2.60× | — | ||
| Q1 25 | 3.07× | — | ||
| Q4 24 | -2.09× | — | ||
| Q3 24 | 3.45× | — | ||
| Q2 24 | 3.71× | — | ||
| Q1 24 | 6.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LQDT
| RSCG | $82.0M | 68% |
| Gov Deals | $22.3M | 18% |
| CAG | $11.5M | 9% |
| Machinio And Software Solutions Corporation | $5.5M | 5% |
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
